Survival in a real-world cohort of patients with transthyretin amyloid cardiomyopathy treated with tafamidis: an analysis from the Transthyretin Amyloidosis Outcomes Survey PC149 (#8)Pablo García‐Pavía, Mat Maurer, Brian Drachman et al.|Unknown|2024Cited by 1